Insider Buying
Use the Insider Buying page to follow recent insider purchase reports, insider-focused slideshows, SEC filing alerts, and related stock research from The Online Investor.
Insider buying can be a useful research signal because it shows company insiders using their own money to purchase shares. It should still be reviewed alongside the size of the purchase, the insider’s role, prior trading history, company fundamentals, valuation, liquidity, and the broader market context.
Insider buying summary
- Page type: insider buying research hub
- Includes: insider purchase reports, featured insider-buying slideshows, SEC filing alerts, related quotes, videos, and stock research screens
- Use this page to: review notable insider purchases and move into ticker-level stock research
Insider buying does not guarantee future stock performance. Insider purchases can vary in size, timing, intent, and significance. Review SEC filings, company fundamentals, valuation, liquidity, and risk before using insider activity as an investment signal.
Latest insider buying report
The latest insider buying report below highlights recent insider purchase activity and related ticker research.
Thursday 9/10 Insider Buying Report: SEI, GRCEThe Online Investor - 9 hours, 1 minute agoAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Tuesday, Solaris Energy Infrastructure's Director, AJ Teague, made a $500,994 purchase of SEI, buying 7,800 shares at a cost of $64.23 each. Solaris Energy Infrastructure is trading off about 1.9% on the day Thursday. Before this latest buy, Teague made one other buy in the past twelve months, purchasing $199,214 shares for a cost of $43.12 each. And on Wednesday, Chief Executive Officer Prashant Kohli purchased $214,000 worth of Grace Therapeutics, purchasing 100,000 shares at a cost of $2.14 each. This buy marks the first one filed by Kohli in the past year. Grace Therapeutics is trading up about 5.7% on the day Thursday. So far Kohli is in the green, up about 7.9% on their purchase based on today's trading high of $2.31.
